Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
SELLAS Life Sciences Group, Inc. (SLS) had Free Cash Flow per Share of $-0.09 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-9.61M |
|
-- |
|
-- |
|
$10.63M |
|
$-10.63M |
|
$1.02M |
|
$-9.61M |
|
$-9.61M |
|
$-9.61M |
|
$-9.61M |
|
$-9.61M |
|
$-9.61M |
|
$-10.63M |
|
$-10.63M |
|
189.18M |
|
189.18M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$142.50M |
|
-- |
|
$2.88M |
|
$145.38M |
|
$7.57M |
|
-- |
|
$0.16M |
|
$7.73M |
|
$137.66M |
|
$135.74M |
|
$137.66M |
|
201.92M |
|
| Cash Flow Statement Financials | |
$-16.43M |
|
-- |
|
$82.98M |
|
$71.89M |
|
$138.44M |
|
$66.55M |
|
$1.81M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.98% |
|
-7.08% |
|
-6.61% |
|
-6.98% |
|
$0.68 |
|
|
Free Cash Flow per Share |
$-0.09 |
$-0.09 |
|